Ophthalmic Viscoelastic Device - OVD Market Analysis 2026

Global Ophthalmic Viscoelastic Device - OVD Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Ophthalmic Viscoelastic Device - OVD Market Report Description

We have various report editions of Ophthalmic Viscoelastic Device - OVD Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Ophthalmic Viscoelastic Device - OVD Market

The competitive landscape of the Ophthalmic Viscoelastic Device (OVD) market is characterized by the presence of several established players as well as emerging companies. Key players in the market are focused on strategic initiatives such as product launches, partnerships, mergers, and acquisitions to strengthen their market position and expand their product portfolio.

Ophthalmic Viscoelastic Device - OVD industry news

In May 2020:The ophthalmic viscoelastic device (OVD) properties from Croma, an Austrian firm that specialises in the most cutting- edge manufacturing line of hyaluronic acid products in the world, have been acquired by BVI, the fastest expanding diversified company in ophthalmology.

(Source: https://www.prnewswire.com/news-releases/bvi-expands-portfolio-with-new-viscoelastic-forges-strategic-partnership-with-croma-301060210.html)

In Jan. 2022: The U.S. Food and Drug Administration (FDA) has granted the 510(k) clearance for Glaukos Corporation's iPRIMETM Viscodelivery System, a sterile, single-use, minimally invasive device for the delivery of viscoelastic fluid during ophthalmic surgery.

(Source:https://investors.glaukos.com/investors/news/news-details/2022/Glaukos-Announces-FDA-510k-Clearance-of-iPRIME/default.aspx)

Top Companies Market Share in Ophthalmic Viscoelastic Device - OVD Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Market Regional analysis of the Ophthalmic Viscoelastic Device - OVD Market

Which Region Dominates the Ophthalmic Viscoelastic Device - OVD Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. North America's dominance in the Ophthalmic Viscoelastic Device (OVD) Market is attributed to several key factors. Firstly, the region has a well-established healthcare infrastructure and a high prevalence of eye-related disorders, leading to a significant demand for OVDs. Secondly, North America is home to several major ophthalmic device manufacturers and research institutions, contributing to a strong market presence and continuous innovation in the field. Additionally, favorable reimbursement policies and high healthcare spending in countries like the United States have further fueled the adoption of OVDs.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific is emerging as the fastest-growing region in the Ophthalmic Viscoelastic Device (OVD) Market due to several key factors. Firstly, the region's rapidly growing elderly population, coupled with increasing access to healthcare services and advancements in ophthalmic care, has led to a surge in demand for OVDs. Secondly, rising disposable incomes and improving healthcare infrastructure in countries like China, India, and Japan have contributed to the market's expansion. Additionally, the increasing prevalence of eye-related disorders and a growing number of ophthalmic surgeries in the region have boosted the adoption of OVDs.

The current report Scope analyzes Ophthalmic Viscoelastic Device - OVD Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Ophthalmic Viscoelastic Device - OVD Market Analysis

According to Cognitive Market Research, the global Ophthalmic Viscoelastic Device - OVD market size was estimated at USD 2615.2 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1046.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031. Segmentation analysis reveals a market divided by product type, including dispersive, cohesive, and combined OVDs. Dispersive OVDs are commonly used in complex surgical procedures, while cohesive OVDs are preferred for their ease of use and predictable performance. In conclusion, the OVD market in North America is poised for growth, driven by factors such as technological advancements, increasing adoption of minimally invasive surgical techniques, and the growing demand for ophthalmic surgeries

• According to Cognitive Market Research, the US had a major share in the Ophthalmic Viscoelastic Device - OVDs market with a market size of USD 825.36 million in 2024 and is projected to grow at a CAGR of 2.5% during the forecast period. The demand is amplified by the nation's aging population, increasing prevalence of ophthalmic disorders, and advancements in surgical techniques propel consistent growth. 
• The Canada Ophthalmic Viscoelastic Device - OVDs market had a market share of USD 125.53 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. Canada's increasing adoption of minimally invasive surgical techniques.
• The Mexico Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 3.2% during the forecast period with a market size of USD 95.19 million in 2024.

Europe Ophthalmic Viscoelastic Device - OVD Market Analysis

According to Cognitive Market Research, the global Ophthalmic Viscoelastic Device - OVD market size was estimated at USD 2615.2 Million out of which Europe market of more than 30% of the global revenue with a market size of USD 237462.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 29.0% from 2024 to 2031. In Europe, the Ophthalmic Viscoelastic Device (OVD) market is a mature yet evolving sector, driven by factors such as an aging population, increasing incidence of ophthalmic disorders, and advancements in surgical techniques. Segmentation analysis reveals a market divided by product type, including dispersive, cohesive, and combined OVDs. Dispersive OVDs are often used in complex surgical procedures, while cohesive OVDs are favored for their ease of use and predictable performance. In conclusion, the OVD market in Europe is characterized by a competitive landscape and technological advancements. To succeed in this market, manufacturers should focus on innovation, product development, and strategic partnerships to meet the diverse needs of ophthalmic surgeons and patients in the region.

• The United Kingdom Ophthalmic Viscoelastic Device - OVDs market had a market share of USD 131.81 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. In the UK, Ophthalmic Viscoelastic Device - OVD sales witness an upswing due to the nation's aging population, increasing incidence of ophthalmic disorders, and advancements in surgical techniques.
• The France Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 2.2% during the forecast period with a market size of USD 72.18 million in 2024.
• According to Cognitive Market Research, the Germany Ophthalmic Viscoelastic Device - OVDs market size was valued at USD 155.34 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. In Germany, Ophthalmic Viscoelastic Device - OVD sales surge due to the advancements in surgical techniques. 
• The Italy Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 2.4% during the forecast period with a market size of USD 67.47 million in 2024.
• The Russia Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 2.0% during the forecast period with a market size of USD 121.61 million in 2024.
• The Spain Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 2.1% during the forecast period with a market size of USD 64.33 million in 2024.
• The Luxembourg Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 24.32 million in 2024.
• The Portugal Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 2.8% during the forecast period with a market size of USD 16.48 million in 2024.
• The Greece Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 3.3% during the forecast period with a market size of USD 9.41 million in 2024.
• Rest of Europe Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 1.7% during the forecast period with a market size of USD 121.61 million in 2024.

Asia Pacific Ophthalmic Viscoelastic Device - OVD Market Analysis

According to Cognitive Market Research, the global Ophthalmic Viscoelastic Device - OVD market size was estimated at USD 2615.2 Million out of which Asia Pacific is the fastest growing market of more than 23% of the global revenue with a market size of USD 601.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031. In Asia Pacific, the Ophthalmic Viscoelastic Device (OVD) market is experiencing rapid growth, driven by factors such as an increasing elderly population, rising prevalence of ophthalmic disorders, and advancements in healthcare infrastructure. Segmentation analysis reveals a market divided by product type, including dispersive, cohesive, and combined OVDs. Dispersive OVDs are often used in intricate surgical procedures, while cohesive OVDs are favored for their ease of use and consistent performance. In conclusion, the OVD market in Asia Pacific is characterized by rapid technological advancements and increasing adoption of minimally invasive surgical techniques.

• According to Cognitive Market Research, the China Ophthalmic Viscoelastic Device - OVDs market size was valued at USD 270.67 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Ophthalmic Viscoelastic Device - OVD sales surge in China due to the nation's rising prevalence of ophthalmic disorders, and advancements in healthcare infrastructure.
• The Japan Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 5.0% during the forecast period with a market size of USD 83.01 million in 2024.
• The India Ophthalmic Viscoelastic Device - OVDs market had a market share of USD 72.18 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. The demand is augmented by India's advancements in healthcare infrastructure.
• The South Korea Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 60.15 million in 2024.
• The Australia Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 6.2% during the forecast period with a market size of USD 31.28 million in 2024.
• The South East Asia Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 7.5% during the forecast period with a market size of USD 41.50 million in 2024.
• The Rest of Asia Pacific Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 6.3% during the forecast period with a market size of USD 42.71 million in 2024.

South America Ophthalmic Viscoelastic Device - OVD Market Analysis

According to Cognitive Market Research, the global Ophthalmic Viscoelastic Device - OVD market size was estimated at USD 2615.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 130.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031. In Latin America, the Ophthalmic Viscoelastic Device (OVD) market is a growing sector, driven by factors such as an aging population, increasing prevalence of ophthalmic disorders, and advancements in surgical techniques. Segmentation analysis reveals a market divided by product type, including dispersive, cohesive, and combined OVDs. Dispersive OVDs are often used in complex surgical procedures, while cohesive OVDs are favored for their ease of use and predictable performance. In conclusion, the OVD market in Latin America presents significant opportunities for growth, driven by factors such as increasing healthcare infrastructure, rising disposable incomes, and a growing awareness of ophthalmic health.

• According to Cognitive Market Research, the Brazil Ophthalmic Viscoelastic Device - OVDs market size was valued at USD 55.97 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Ophthalmic Viscoelastic Device - OVD sales flourish in Brazil due to the nation's aging population, increasing prevalence of ophthalmic disorders.
• The Argentina Ophthalmic Viscoelastic Device - OVDs market had a market share of USD 21.97 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. The demand is augmented by Argentina's advancements in surgical techniques.
• The Colombia Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 3.7% during the forecast period with a market size of USD 11.64 million in 2024.
• The Peru Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 4.1% during the forecast period with a market size of USD 10.72 million in 2024.
• The Chile Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 7.9% during the forecast period with a market size of USD 9.41million in 2024.
• The Rest of Latin America Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 3.0% during the forecast period with a market size of USD 21.05 million in 2024.

Middle East Ophthalmic Viscoelastic Device - OVD Market Analysis

According to Cognitive Market Research, the global Ophthalmic Viscoelastic Device - OVD market size was estimated at USD 2615.2 Million out of which Middle East and Africa market of more than 2.00% of the global revenue with a market size of USD 52.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031. In the Middle East and Africa (MEA) region, the Ophthalmic Viscoelastic Device (OVD) market is a burgeoning sector, driven by factors such as an increasing elderly population, rising incidence of ophthalmic disorders, and advancements in healthcare infrastructure. Segmentation analysis reveals a market divided by product type, including dispersive, cohesive, and combined OVDs. Dispersive OVDs are often used in intricate surgical procedures, while cohesive OVDs are favored for their ease of use and consistent performance. In conclusion, the OVD market in the Middle East and Africa presents significant opportunities for growth, driven by factors such as increasing healthcare investments, rising patient awareness, and a growing number of ophthalmic surgeries.

• According to Cognitive Market Research, the GCC Countries Ophthalmic Viscoelastic Device - OVDs market size was valued at USD 22.39 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Ophthalmic Viscoelastic Device - OVD sales flourish in the GCC Countries due to the region's strategic investments in healthcare research and advancements.
• The Egypt Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 4.5% during the forecast period with a market size of USD 5.49 million in 2024.
• The South Africa Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 5.2% during the forecast period with a market size of USD 8.26 million in 2024.Ophthalmic Viscoelastic Device - OVD sales flourish in the South Africa due to the advancements in healthcare infrastructure.
• The Turkey Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 3.7% during the forecast period with a market size of USD 4.50 million in 2024.
• The Nigeria Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 3.3% during the forecast period with a market size of USD 5.49 million in 2024.
• The Rest of MEA Ophthalmic Viscoelastic Device - OVDs market is projected to witness growth at a CAGR of 3.2% during the forecast period with a market size of USD 6.17 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst at Cognitive Market Research

LinkedIn | Profile | Book Appointment

Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.